Increased Expression of the p-STAT3/IL-17 Signaling pathway in patients with Dermatomyositis.

Li, Dongmei; Jia, Wen; Zhou, Luyao; Hao, Yiqun; Wang, Kai; Yang, Bo; Yang, Jie; Luo, Dongping; Fu, Zili

Li, Dongmei; Jia, Wen; Zhou, Luyao; Hao, Yiqun; Wang, Kai; Yang, Bo; Yang, Jie; Luo, Dongping; Fu, Zili.

Afiliación

Li D; Department of Rheumatology, the First Hospital of Shanxi Medical University, Taiyuan, China.
Jia W; Department of Rheumatology, the First Hospital of Shanxi Medical University, Taiyuan, China.
Zhou L; Department of Rheumatology, the First Hospital of Shanxi Medical University, Taiyuan, China.
Hao Y; Department of Rheumatology, the First Hospital of Shanxi Medical University, Taiyuan, China.
Wang K; Department of Rheumatology, the First Hospital of Shanxi Medical University, Taiyuan, China.
Yang B; Department of Rheumatology, the First Hospital of Shanxi Medical University, Taiyuan, China.
Yang J; Department of Rheumatology, the First Hospital of Shanxi Medical University, Taiyuan, China.
Luo D; Department of Rheumatology, the First Hospital of Shanxi Medical University, Taiyuan, China.
Fu Z; Department of Rheumatology, the First Hospital of Shanxi Medical University, Taiyuan, China.

Mod Rheumatol ; 2022 Dec 08.

Article en En | MEDLINE | ID: mdl-36478263

Palabras clave

IL-17; Th17 cells; dermatomyositis; p-STAT3

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Mod Rheumatol Año: 2022 Tipo del documento: Article País de afiliación: China

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google